NEUROGASTRX INC. Overview
Upcoming Projects (NEUROGASTRX INC.)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (NEUROGASTRX INC.)
-
A Third Opinion: Discussing the use of GLP-1 agonists and the potential of Neurogastrx Inc. NG101 (metopimazine mesylate), currently being studied to limit nausea and vomiting side effects caused by GLP-1 agonist medications.
Tickers: NEUROGASTRX INC., NVO, LLY
Executed On: Jan 17, 2025 at 12:00 PM EST -
A Second Opinion: Discussing the use of GLP-1 agonists and the potential of Neurogastrx Inc. NG101 (metopimazine mesylate), currently being studied to limit nausea and vomiting side effects caused by GLP-1 agonist medications.
Tickers: NEUROGASTRX INC., NVO, LLY
Executed On: Jan 17, 2025 at 10:00 AM EST
Upcoming & Overdue Catalysts (NEUROGASTRX INC.)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (NEUROGASTRX INC.)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
